Boehringer Ingelheim Statement on Hepatitis C drug development
- Details
- Category: Boehringer Ingelheim

James C. Smith elected to Pfizer's Board of Directors
- Details
- Category: Pfizer

Abbott to acquire Veropharm
- Details
- Category: Abbott

Sanofi and Medtronic to form strategic alliance
- Details
- Category: Sanofi

Roche Children's Walk 2014
- Details
- Category: Roche

Pfizer and Cellectis enter into global strategic cancer immunotherapy collaboration
- Details
- Category: Pfizer

Pfizer opens new state-of-the-Art research and development site in Cambridge, Massachusetts
- Details
- Category: Pfizer

More Pharma News ...
- Mindprint implements market-leading automation solution for Ockham Oncology
- Sanofi and Lilly announce licensing agreement for Cialis® (tadalafil) OTC
- Bristol-Myers Squibb and Syngene International extend research collaboration
- AstraZeneca updates on the rapid progress of its oncology pipeline at ASCO 2014
- Bayer and Orion Corporation to develop and commercialize novel prostate cancer treatment
- Pfizer and the Avon Foundation for Women announce $1 million grants program
- Novartis launches 7-Day Challenge to 'Live Like You' enabling people with MS to better understand their lives with MS